{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:46:28Z","timestamp":1761561988212},"reference-count":38,"publisher":"Society of Nuclear Medicine","issue":"Supplement 4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.2967\/jnumed.114.142778","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T15:00:23Z","timestamp":1433170823000},"page":"20S-24S","source":"Crossref","is-referenced-by-count":5,"title":["Neuronal Dysfunction and Medical Therapy in Heart Failure: Can an Imaging Biomarker Help to \u201cPersonalize\u201d Therapy?"],"prefix":"10.2967","volume":"56","author":[{"given":"Benjamin S.","family":"Wessler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Udelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"key":"2021051712083140000_56.Supplement_4.20S.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8776"},{"key":"2021051712083140000_56.Supplement_4.20S.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410806"},{"key":"2021051712083140000_56.Supplement_4.20S.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198409273111303"},{"key":"2021051712083140000_56.Supplement_4.20S.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2009.07.014"},{"key":"2021051712083140000_56.Supplement_4.20S.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2011.04.001"},{"key":"2021051712083140000_56.Supplement_4.20S.6","doi-asserted-by":"publisher","DOI":"10.1067\/mnc.2002.121471"},{"key":"2021051712083140000_56.Supplement_4.20S.7","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(88)92608-3"},{"key":"2021051712083140000_56.Supplement_4.20S.8","first-page":"471","article-title":"Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure","volume":"33","author":"Merlet","year":"1992","journal-title":"J Nucl Med."},{"key":"2021051712083140000_56.Supplement_4.20S.9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000053"},{"key":"2021051712083140000_56.Supplement_4.20S.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.01.014"},{"key":"2021051712083140000_56.Supplement_4.20S.11","unstructured":"AdreView prescribing information. GE Healthcare website. http:\/\/www3.gehealthcare.com\/en\/products\/categories\/nuclear_imaging_agents\/adreview. Accessed February 23, 2015."},{"key":"2021051712083140000_56.Supplement_4.20S.12","first-page":"56","article-title":"Clinical usefulness of myocardial innervation imaging using iodine-123-meta-iodobenzylguanidine scintigraphy in evaluating the effectiveness of pharmacological treatments in patients with heart failure: an overview","volume":"17","author":"Treglia","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"2021051712083140000_56.Supplement_4.20S.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.011"},{"key":"2021051712083140000_56.Supplement_4.20S.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.111.961573"},{"key":"2021051712083140000_56.Supplement_4.20S.15","doi-asserted-by":"publisher","DOI":"10.1067\/mnc.2001.109452"},{"key":"2021051712083140000_56.Supplement_4.20S.16","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.112783"},{"key":"2021051712083140000_56.Supplement_4.20S.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105313442201"},{"key":"2021051712083140000_56.Supplement_4.20S.18","doi-asserted-by":"crossref","unstructured":"Gerson MC, Craft LL, McGuire N, Suresh DP, Abraham WT, Wagoner LE. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. J Nucl Cardiol. 2002;9:608\u2013615.","DOI":"10.1067\/mnc.2002.127717"},{"key":"2021051712083140000_56.Supplement_4.20S.19","doi-asserted-by":"crossref","unstructured":"Arora R, Ferrick KJ, Nakata T, et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol. 2003;10:121\u2013131.","DOI":"10.1067\/mnc.2003.2"},{"key":"2021051712083140000_56.Supplement_4.20S.20","doi-asserted-by":"crossref","unstructured":"Al Badarin FJ, Wimmer AP, Kennedy KF, Jacobson AF, Bateman TM. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy. J Nucl Cardiol. 2014;21:756\u2013762.","DOI":"10.1007\/s12350-014-9919-z"},{"key":"2021051712083140000_56.Supplement_4.20S.21","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-014-9932-2"},{"key":"2021051712083140000_56.Supplement_4.20S.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.013"},{"key":"2021051712083140000_56.Supplement_4.20S.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.097709"},{"key":"2021051712083140000_56.Supplement_4.20S.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000380"},{"key":"2021051712083140000_56.Supplement_4.20S.25","doi-asserted-by":"crossref","unstructured":"Sipahi I, Chou JC, Hyden M, Rowland DY, Simon DI, Fang JC. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J. 2012;163:260\u2013267.e3.","DOI":"10.1016\/j.ahj.2011.11.014"},{"key":"2021051712083140000_56.Supplement_4.20S.26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.956011"},{"key":"2021051712083140000_56.Supplement_4.20S.27","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-012-9603-0"},{"key":"2021051712083140000_56.Supplement_4.20S.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80353-1"},{"key":"2021051712083140000_56.Supplement_4.20S.29","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.76.3.218"},{"key":"2021051712083140000_56.Supplement_4.20S.30","first-page":"523","article-title":"Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy","volume":"24","author":"Fukuoka","year":"1997","journal-title":"Eur J Nucl Med."},{"key":"2021051712083140000_56.Supplement_4.20S.31","first-page":"1085","article-title":"ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure","volume":"38","author":"Takeishi","year":"1997","journal-title":"J Nucl Med."},{"key":"2021051712083140000_56.Supplement_4.20S.32","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.39.743"},{"key":"2021051712083140000_56.Supplement_4.20S.33","first-page":"217","article-title":"Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after \u03b2-blocker or angiotensin-converting enzyme inhibitor therapy","volume":"40","author":"Toyama","year":"1999","journal-title":"J Nucl Med."},{"key":"2021051712083140000_56.Supplement_4.20S.34","first-page":"845","article-title":"Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study","volume":"41","author":"Agostini","year":"2000","journal-title":"J Nucl Med."},{"key":"2021051712083140000_56.Supplement_4.20S.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02855-3"},{"key":"2021051712083140000_56.Supplement_4.20S.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nuclcard.2003.11.006"},{"key":"2021051712083140000_56.Supplement_4.20S.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.038"},{"key":"2021051712083140000_56.Supplement_4.20S.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(97)70232-1"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.114.142778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:04:30Z","timestamp":1621281870000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.114.142778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":38,"journal-issue":{"issue":"Supplement 4","published-online":{"date-parts":[[2015,6,1]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.2967\/jnumed.114.142778"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.114.142778","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}